Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02561702Phase 2Completed
Phase 2, randomised, double-blind trial of mexiletine in muscle cramps (2 arms), sponsored by University of Rochester. Primary endpoints: Number of Participants With a Decrease in Cramp Duration at 120 minutes and Number of Participants With a Decrease in Cramp Intensity at 120 minutes. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02561702.